P&G, Avon Focus on U.S. Growth

Ending its fiscal year on a positive note, Procter & Gamble’s beauty business saw a 1 percent uptick in net sales in the fourth quarter, with organic sales up 3 percent. Globally, P&G’s prestige beauty business climbed mid-single digits. For P&G, U.S. market continues to be troublesome.

more

P&G, Avon Focus on U.S. Growth

Ending its fiscal year on a positive note, Procter & Gamble’s beauty business saw a 1 percent uptick in net sales in the fourth quarter, with organic sales up 3 percent. Globally, P&G’s prestige beauty business climbed mid-single digits. For P&G, U.S. market continues to be troublesome.

more

REVLON 2Q SALES DIP, PROFITS UP

Revlon’s sales fell in the second quarter driven by costs associated with a restage of the Almay brand, while its nail color businesses remained bright spots.

more

L’Oréal Outperforms Market in First Half

L’Oréal posted first half sales for 2013, with positive results across its various divisions, and market share gains seen in Western Europe and North America, stemming from the Active Cosmetics Division and L’Oréal Paris in Western Europe, and Garnier, Lancôme, Giorgio Armani and Kiehl’s in North America.

more

Arden CEO Outlines 2013 Plans in 4Q/FY Call

Elizabeth Arden closed out its fiscal year on a high note, with net sales up 5.3% to $1.2 billion. In North America, sales edged up 2.9% to $778.4 million benefitting from its prestige business, while internationally net sales jumped 9.8% to $459.9 million with Europe, travel retail and developing markets contributing the most gains. For the quarter, net sales grew 4.6%.

more

Top 4 Highlights From P&G 4Q Call

In a year of transformation that designated Singapore as its new beauty headquarters and saw the departure of beauty executives Ed Shirley and Virginia Drosos, Procter & Gamble capped fiscal 2012 with fourth quarter net beauty sales down 4% to $4.8 billion. The company said organic sales (which exclude the impact of foreign exchange and acquisitions) rose 1%. Sales in developing markets continued to expand, now representing 40% of P&G’s total revenue, as many developed markets underperformed. To correct slipping sales of Olay and Pantene in the U.S., P&G plans to increase innovation, boost advertising and maintain a vertical approach. “It is still a strategy for us to have a full offering in every category,” said Bob McDonald, P&G’s CEO, speaking on a conference call Friday. P&G executives presented a corporate initiative to accelerate the momentum of new markets and jumpstart the old. Here are four main highlights from the call.

more

Top 4 Highlights From P&G 4Q Call

In a year of transformation that designated Singapore as its new beauty headquarters and saw the departure of beauty executives Ed Shirley and Virginia Drosos, Procter & Gamble capped fiscal 2012 with fourth quarter net beauty sales down 4% to $4.8 billion. The company said organic sales (which exclude the impact of foreign exchange and acquisitions) rose 1%. Sales in developing markets continued to expand, now representing 40% of P&G’s total revenue, as many developed markets underperformed. To correct slipping sales of Olay and Pantene in the U.S., P&G plans to increase innovation, boost advertising and maintain a vertical approach. “It is still a strategy for us to have a full offering in every category,” said Bob McDonald, P&G’s CEO, speaking on a conference call Friday. P&G executives presented a corporate initiative to accelerate the momentum of new markets and jumpstart the old. Here are four main highlights from the call.

more

The Top 3 Analyst Remarks During Avon’s Investor Call

On her 100th day as Avon’s CEO, Sherilyn McCoy was peppered with analyst questions about a turnaround plan she shared with the release of another disappointing financial report. In the second quarter Avon’s sales fell 9% or 1% in constant dollars, with a 3% drop in representatives globally. Sheri outlined a multiple point approach focused on stabilizing the business by fixing existing issues, rather than setting a new course. Here’s how Sheri addressed specific analyst concerns.

more